Volga M 0.2/500MG

Composition

Metformin hydrochloride 500 mg + Voglibose 0.2 mg (tablet)

Uses of Volga M 0.2/500MG

Type 2 diabetes mellitus; helps control post‑meal (postprandial) blood glucose in adults when diet/exercise and/or other antidiabetic medicines are insufficient.

• •Reduces post-meal blood sugar spikes
• •Lowers fasting and overall glucose (HbA1c) when combined with diet/exercise
• •Improves insulin sensitivity
• •Helps better glycaemic control with dual mechanism

How it works

Voglibose is an alpha‑glucosidase inhibitor that delays breakdown and absorption of carbohydrates in the intestine, reducing post‑meal glucose spikes. Metformin decreases hepatic glucose production and improves insulin sensitivity, lowering fasting and overall blood glucose.

Directions for use

Take orally as prescribed, usually with or immediately after meals to reduce stomach upset. Swallow tablet whole with water; do not crush/chew unless advised. Follow diet and exercise plan and monitor blood glucose regularly.

Side effects

Common side effects of Volga M 0.2/500MG may include:

• •Diarrhoea
• •nausea
• •vomiting
• •abdominal pain
• •flatulence
• •